Amylgen

Amylgen is a private French preclinical contract research organization focused on central nervous system disorders and brain health. The company provides in vivo rodent models, behavioral testing, biochemistry, histology, immunohistochemistry, and related preclinical services to pharmaceutical, biotechnology, and nutraceutical clients. Its offerings are centered on rapid proof-of-concept and efficacy evaluation in models of neurodegenerative, psychiatric, cognitive, and ageing-related conditions. Amylgen was founded as a spin-off of the University of Montpellier and operates its own certified animal research facility. Rather than advancing a proprietary clinical drug pipeline, the company primarily sells discovery and preclinical research services.